Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
1.
Clin Chem ; 64(2): 297-306, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29122836

RESUMO

BACKGROUND: Molecular characterization of circulating tumor cells (CTCs) is important for selecting patients for targeted treatments. We present, for the first time, results on gene expression profiling of CTCs isolated in vivo from high-risk prostate cancer (PCa) patients compared with CTC detected by 3 protein-based assays-CellSearch®, PSA-EPISPOT, and immunofluorescence of CellCollector® in vivo-captured CTCs-using the same blood draw. METHODS: EpCAM-positive CTCs were isolated in vivo using the CellCollector from 108 high-risk PCa patients and 36 healthy volunteers. For 27 patients, samples were available before and after treatment. We developed highly sensitive multiplex RT-qPCR assays for 14 genes (KRT19, EpCAM, CDH1, HMBS, PSCA, ALDH1A1, PROM1, HPRT1, TWIST1, VIM, CDH2, B2M, PLS3, and PSA), including epithelial markers, stem cell markers, and epithelial-to-mesenchymal-transition (EMT) markers. RESULTS: We observed high heterogeneity in gene expression in the captured CTCs for each patient. At least 1 marker was detected in 74 of 105 patients (70.5%), 2 markers in 45 of 105 (40.9%), and 3 markers in 16 of 105 (15.2%). Epithelial markers were detected in 31 of 105 (29.5%) patients, EMT markers in 46 of 105 (43.8%), and stem cell markers in 15 of 105 (14.3%) patients. EMT-marker positivity was very low before therapy (2 of 27, 7.4%), but it increased after therapy (17 of 27, 63.0%), whereas epithelial markers tended to decrease after therapy (2 of 27, 7.4%) compared with before therapy (13 of 27, 48.1%). At least 2 markers were expressed in 40.9% of patients, whereas the positivity was 19.6% for CellSearch, 38.1% for EPISPOT, and 43.8% for CellCollector-based IF-staining. CONCLUSIONS: The combination of in vivo CTC isolation with downstream RNA analysis is highly promising as a high-throughput, specific, and ultrasensitive approach for multiplex liquid biopsy-based molecular diagnostics.


Assuntos
Perfilação da Expressão Gênica/métodos , Reação em Cadeia da Polimerase Multiplex/métodos , Células Neoplásicas Circulantes/metabolismo , Neoplasias da Próstata/sangue , Neoplasias da Próstata/genética , Estudos de Casos e Controles , Ensaio de Imunoadsorção Enzimática/métodos , Molécula de Adesão da Célula Epitelial/sangue , Transição Epitelial-Mesenquimal/genética , Imunofluorescência/métodos , Heterogeneidade Genética , Humanos , Masculino , Antígeno Prostático Específico/sangue , Sensibilidade e Especificidade
2.
Clin Chem ; 64(3): 536-546, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29301749

RESUMO

BACKGROUND: Liquid biopsies can be used in castration-resistant prostate cancer (CRPC) to detect androgen receptor splice variant 7 (AR-V7), a splicing product of the androgen receptor. Patients with AR-V7-positive circulating tumor cells (CTCs) have greater benefit of taxane chemotherapy compared with novel hormonal therapies, indicating a treatment-selection biomarker. Likewise, in those with pancreatic cancer (PaCa), KRAS mutations act as prognostic biomarkers. Thus, there is an urgent need for technology investigating the expression and mutation status of CTCs. Here, we report an approach that adds AR-V7 or KRAS status to CTC enumeration, compatible with multiple CTC-isolation platforms. METHODS: We studied 3 independent CTC-isolation devices (CellCollector, Parsortix, CellSearch) for the evaluation of AR-V7 or KRAS status of CTCs with in situ padlock probe technology. Padlock probes allow highly specific detection and visualization of transcripts on a cellular level. We applied padlock probes for detecting AR-V7, androgen receptor full length (AR-FL), and prostate-specific antigen (PSA) in CRPC and KRAS wild-type (wt) and mutant (mut) transcripts in PaCa in CTCs from 46 patients. RESULTS: In situ analysis showed that 71% (22 of 31) of CRPC patients had detectable AR-V7 expression ranging from low to high expression [1-76 rolling circle products (RCPs)/CTC]. In PaCa patients, 40% (6 of 15) had KRAS mut expressing CTCs with 1 to 8 RCPs/CTC. In situ padlock probe analysis revealed CTCs with no detectable cytokeratin expression but positivity for AR-V7 or KRAS mut transcripts. CONCLUSIONS: Padlock probe technology enables quantification of AR-V7, AR-FL, PSA, and KRAS mut/wt transcripts in CTCs. The technology is easily applicable in routine laboratories and compatible with multiple CTC-isolation devices.


Assuntos
Análise Mutacional de DNA/métodos , Calicreínas/genética , Mutação Puntual , Antígeno Prostático Específico/genética , Proteínas Proto-Oncogênicas p21(ras)/genética , Receptores Androgênicos/genética , Idoso , Idoso de 80 Anos ou mais , Linhagem Celular Tumoral , Separação Celular/instrumentação , Separação Celular/métodos , Análise Mutacional de DNA/instrumentação , Sondas de DNA , Feminino , Humanos , Dispositivos Lab-On-A-Chip , Antígenos Comuns de Leucócito/imunologia , Antígenos Comuns de Leucócito/metabolismo , Masculino , Células Neoplásicas Circulantes/patologia , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/patologia , Neoplasias de Próstata Resistentes à Castração/genética , Neoplasias de Próstata Resistentes à Castração/patologia
3.
Histochem Cell Biol ; 148(2): 105-115, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28321501

RESUMO

Tumor heterogeneity is considered a major cause for therapy resistance in colorectal cancer. Sub-populations of cells with different genetic alterations may exist in spatially distinct areas. Upon therapy, resistant sub-clones may enrich and ultimately lead to disease progression. Although ample data are available on tumors which are heterogeneous on a morphological level, only little is known about morphologically homogeneous tumors. We aimed to investigate if morphologically homogeneous colorectal cancer can harbor a heterogeneous genetic landscape. We chose to microdissect six morphologically homogeneous colorectal carcinomas into several areas and performed next-generation sequencing (NGS) to identify tumors with genetic heterogeneity. We then applied an mRNA-based in situ mutation detection technology based on padlock probes to localize and visualize mutations directly in the tumor tissue. In three out of six tumors, NGS revealed a high rate of variability of mutations between different tumor areas. We selected two cases for in situ mutation detection to visualize genetic heterogeneity. In situ mutation detection confirmed differences in mutant allele frequencies between different tumor areas of morphological homogeneous tumors. We conclude that genetic heterogeneity in morphologically homogeneous colorectal cancer is an observable, but underreported event. Our results illustrate the power of in situ mutation analysis to visualize genetic heterogeneity directly in tumor tissue.


Assuntos
Neoplasias Colorretais/genética , Análise Mutacional de DNA , Heterogeneidade Genética , Linhagem Celular Tumoral , Neoplasias Colorretais/patologia , Humanos , Mutação Puntual/genética
4.
Fetal Diagn Ther ; 41(1): 32-40, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-27115893

RESUMO

OBJECTIVES: A key problem in prenatal screening using extra-embryonic cells is the feasibility of extracting usable DNA from a small number of cells. Syncytial nuclear aggregates (SNAs) are multinucleated structures shed from the placenta. This study assesses the potential of SNAs as a source of fetal DNA for the detection of genetic abnormalities. METHODS: SNAs were collected in vitro. Whole-genome amplification was used to amplify DNA from single SNAs, and DNA quality and quantity was assessed by spectrophotometry and PCR. Confocal microscopy was used to count nuclei within SNAs, determine metabolic activity and investigate DNA damage. Fetal sex and chromosomal/genetic abnormalities were investigated with array-comparative genomic hybridization (aCGH). RESULTS: DNA was amplified from 81% of the individual SNAs. A mean of 61 ± 43 nuclei were found per SNA. DNA strand breaks were found in 76% of the SNAs. Seventy-five percent of SNAs yielded whole-genome-amplified DNA of sufficient quality for aCGH after storage and shipping. Individual SNAs from the same pregnancy reliably gave the same chromosomal profile, and fetal sex and trisomies could be detected. A microdeletion was detected in one pregnancy. CONCLUSION: SNAs could provide a source of extra-embryonic DNA for the prenatal screening/diagnosis of fetal sex and chromosomal and sub-chromosomal genetic abnormalities.


Assuntos
Aneuploidia , DNA/química , Diagnóstico Pré-Natal/métodos , Aberrações Cromossômicas , Transtornos Cromossômicos/diagnóstico , Hibridização Genômica Comparativa , Feminino , Humanos , Marcação In Situ das Extremidades Cortadas , Placenta/citologia , Gravidez , Análise para Determinação do Sexo
5.
Mol Biol Evol ; 29(9): 2231-9, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22422764

RESUMO

Eukaryote genomes contain multiple copies of nuclear ribosomal DNA (nrDNA) harboring both highly conserved and variable regions. This has made nrDNA the most popular genetic marker for phylogenetic studies and the region of choice for barcoding projects. Furthermore, many scientists believe that all copies of nrDNA within one nucleus are practically identical due to concerted evolution. Here, we investigate the model plant species Arabidopsis thaliana for intragenomic variation of the internal transcribed spacer (ITS) region of nrDNA. Based on a modified deep sequencing approach, we provide a comprehensive list of ITS polymorphisms present in the two most widely used accessions of A. thaliana-Col-0 and Ler. Interestingly, we found that some polymorphisms are shared between these genetically very distinct accessions. On the other hand, the high number of accession-specific polymorphisms shows that each accession can be clearly and easily characterized by its specific ITS polymorphism patterns and haplotypes. Network analysis based on the detected haplotypes demonstrates that the study of ITS polymorphism patterns and haplotypes is an extremely powerful tool for population genetics. Using the methods proposed here, it will now be possible to extend the traditionally species-bound barcoding concept to populations.


Assuntos
Arabidopsis/genética , Código de Barras de DNA Taxonômico , DNA Espaçador Ribossômico , Haplótipos , Arabidopsis/classificação , Sequência de Bases , Mutação INDEL , Dados de Sequência Molecular , Filogenia , Polimorfismo Genético
6.
J Transl Med ; 11: 214, 2013 Sep 17.
Artigo em Inglês | MEDLINE | ID: mdl-24044779

RESUMO

BACKGROUND: Single circulating tumor cells (CTCs) or circulating tumor microemboli (CTMs) are potential biomarkers of renal cell cancer (RCC), however studies of CTCs/CTMs in RCC are limited. In this pilot study we aimed to evaluate a novel blood filtration technique suited for cytomorphological classification, immunocytochemical and molecular characterization of filtered, so called circulating non-hematologic cells (CNHCs) - putative CTCs/CTMs - in patients with RCC. METHODS: Blood of 40 patients with renal tumors was subjected to ScreenCell filtration. CNHCs were classified according to cytomorphological criteria. Immunocytochemical analysis was performed with antibodies against CD45, CD31 and carbonic anhydrase IX (CAIX, a RCC marker). DNA of selected CNHCs and respective primary tumors was analysed by array-CGH. RESULTS: CNHC-clusters with malignant or uncertain malignant cytomorphological features - putative CTMs - were negative for CD45, positive for CD31, while only 6% were CAIX positive. Array-CGH revealed that 83% of malignant and uncertain malignant cells did represent with a balanced genome whereas 17% presented genomic DNA imbalances which did not match the aberrations of the primary tumors. Putative single CTCs were negative for CD45, 33% were positive for CD31 and 56% were positive for CAIX. CONCLUSIONS: The majority of CNHC-clusters, putative CTMs, retrieved by ScreenCell filtration may be of endothelial origin. Morphological criteria seem to be insufficient to distinguish malignant from non-malignant cells in renal cancer.


Assuntos
Forma Celular , Neoplasias Renais/patologia , Células Neoplásicas Circulantes/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores Tumorais/metabolismo , Carcinoma de Células Renais/metabolismo , Carcinoma de Células Renais/patologia , Estudos de Casos e Controles , Contagem de Células , Estudos de Coortes , Hibridização Genômica Comparativa , DNA de Neoplasias/metabolismo , Feminino , Humanos , Imuno-Histoquímica , Microdissecção e Captura a Laser , Masculino , Pessoa de Meia-Idade , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo , Fatores de Tempo
7.
Glycobiology ; 22(10): 1374-86, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22752006

RESUMO

Mechanisms accounting for the protection of the fetal semi-allograft from maternal immune cells remain incompletely understood. In previous studies, we showed that galectin-1 (Gal1), an immunoregulatory glycan-binding protein, hierarchically triggers a cascade of tolerogenic events at the mouse fetomaternal interface. Here, we show that Gal1 confers immune privilege to human trophoblast cells through the modulation of a number of regulatory mechanisms. Gal1 was mainly expressed in invasive extravillous trophoblast cells of human first trimester and term placenta in direct contact with maternal tissue. Expression of Gal1 by the human trophoblast cell line JEG-3 was primarily controlled by progesterone and pro-inflammatory cytokines and impaired T-cell responses by limiting T cell viability, suppressing the secretion of Th1-type cytokines and favoring the expansion of CD4(+)CD25(+)FoxP3(+) regulatory T (T(reg)) cells. Targeted inhibition of Gal1 expression through antibody (Ab)-mediated blockade, addition of the specific disaccharide lactose or retroviral-mediated siRNA strategies prevented these immunoregulatory effects. Consistent with a homeostatic role of endogenous Gal1, patients with recurrent pregnancy loss showed considerably lower levels of circulating Gal1 and had higher frequency of anti-Gal1 auto-Abs in their sera compared with fertile women. Thus, endogenous Gal1 confers immune privilege to human trophoblast cells by triggering a broad tolerogenic program with potential implications in threatened pregnancies.


Assuntos
Aborto Habitual/imunologia , Galectina 1/imunologia , Trofoblastos/imunologia , Linhagem Celular , Sobrevivência Celular/imunologia , Citocinas/imunologia , Galectina 1/antagonistas & inibidores , Galectina 1/biossíntese , Humanos , Progesterona/farmacologia , Linfócitos T/citologia , Linfócitos T/imunologia , Trofoblastos/citologia
8.
Wien Med Wochenschr ; 162(9-10): 214-9, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22717876

RESUMO

This review focuses on the placental expression of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase-1 (IDO1) and its potential roles, which may not only encompass immunosuppression and antimicrobial activity, but also vasodilation based on the endothelial expression on both sides of the feto-maternal interface.


Assuntos
Indolamina-Pirrol 2,3,-Dioxigenase/fisiologia , Placenta/fisiopatologia , Infecções Bacterianas/imunologia , Endotélio Vascular/fisiopatologia , Feminino , Retardo do Crescimento Fetal/fisiopatologia , Idade Gestacional , Células Endoteliais da Veia Umbilical Humana , Humanos , Tolerância Imunológica/fisiologia , Recém-Nascido , Troca Materno-Fetal/fisiologia , Placenta/irrigação sanguínea , Pré-Eclâmpsia/fisiopatologia , Gravidez
9.
Clin Chem ; 57(7): 1032-41, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21558453

RESUMO

BACKGROUND: Analysis of chromosomal aberrations or single-gene disorders from rare fetal cells circulating in the blood of pregnant women requires verification of the cells' genomic identity. We have developed a method enabling multiple analyses at the single-cell level that combines verification of the genomic identity of microchimeric cells with molecular genetic and cytogenetic diagnosis. METHODS: We used a model system of peripheral blood mononuclear cells spiked with a colon adenocarcinoma cell line and immunofluorescence staining for cytokeratin in combination with DNA staining with the nuclear dye TO-PRO-3 in a preliminary study to define candidate microchimeric (tumor) cells in Cytospin preparations. After laser microdissection, we performed low-volume on-chip isothermal whole-genome amplification (iWGA) of single and pooled cells. RESULTS: DNA fingerprint analysis of iWGA aliquots permitted successful identification of all analyzed candidate microchimeric cell preparations (6 samples of pooled cells, 7 samples of single cells). Sequencing of 3 single-nucleotide polymorphisms was successful at the single-cell level for 20 of 32 allelic loci. Metaphase comparative genomic hybridization (mCGH) with iWGA products of single cells showed the gains and losses known to be present in the genomic DNA of the target cells. CONCLUSIONS: This method may be instrumental in cell-based noninvasive prenatal diagnosis. Furthermore, the possibility to perform mCGH with amplified DNA from single cells offers a perspective for the analysis of nonmicrochimeric rare cells exhibiting genomic alterations, such as circulating tumor cells.


Assuntos
Análise Citogenética/métodos , Impressões Digitais de DNA/métodos , Genoma Humano , Leucócitos Mononucleares/citologia , Leucócitos Mononucleares/metabolismo , Análise de Célula Única/métodos , Quimerismo , Aberrações Cromossômicas , Hibridização Genômica Comparativa/métodos , Feminino , Imunofluorescência , Células HT29 , Humanos , Queratinas/metabolismo , Metáfase , Células Neoplásicas Circulantes/metabolismo , Células Neoplásicas Circulantes/patologia , Técnicas de Amplificação de Ácido Nucleico , Gravidez , Diagnóstico Pré-Natal/métodos , Análise de Sequência de DNA/métodos
10.
J Cell Mol Med ; 14(4): 954-69, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19453769

RESUMO

The analysis of rare cells is not an easy task. This is especially true when cells representing a fetal microchimerism are to be utilized for the purpose of non-invasive prenatal diagnosis because it is both imperative and difficult to avoid contaminating the minority of fetal cells with maternal ones. Under these conditions, even highly specific biochemical markers are not perfectly reliable. We have developed a method to verify the genomic identity of rare cells that combines automatic screening for enriched target cells (based on immunofluorescence labelling) with isolation of single candidate microchimeric cells (by laser microdissection and subsequent laser catapulting) and low-volume on-chip multiplex PCR for DNA fingerprint analysis. The power of the method was tested using samples containing mixed cells of related and non-related individuals. Single-cell DNA fingerprinting was successful in 74% of the cells analysed (55/74), with a PCR efficiency of 59.2% (860/1452) for heterozygous loci. The identification of cells by means of DNA profiling was achieved in 100% (12/12) of non-related cells in artificial mixtures and in 86% (37/43) of cells sharing a haploid set of chromosomes and was performed on cells enriched from blood and cells isolated from tissue. We suggest DNA profiling as a standard for the identification of microchimerism on a single-cell basis.


Assuntos
Quimerismo , Decídua/citologia , Dispositivos Lab-On-A-Chip , Reação em Cadeia da Polimerase/métodos , Aborto Induzido , Especificidade de Anticorpos/imunologia , Automação/métodos , Linhagem Celular , Vilosidades Coriônicas/metabolismo , Impressões Digitais de DNA , Feminino , Feto/citologia , Citometria de Fluxo , Genoma Humano/genética , Humanos , Imuno-Histoquímica , Leucócitos Mononucleares/citologia , Gravidez , Primeiro Trimestre da Gravidez , Reprodutibilidade dos Testes , Trofoblastos/citologia , Trofoblastos/imunologia
11.
Hypertension ; 76(1): 184-194, 2020 07.
Artigo em Inglês | MEDLINE | ID: mdl-32475317

RESUMO

l-tryptophan induces IDO (indoleamine 2,3-dioxygenase) 1-dependent vasodilation. IDO1 is expressed in placental endothelial cells and downregulated in preeclampsia. Hypothesizing that this may contribute to diminished placental perfusion, we studied l-tryptophan-induced vasodilation in healthy and early-onset preeclampsia placental arteries, focusing on placental kynurenine pathway alterations. Despite IDO1 downregulation, kynurenine pathway metabolite concentrations (measured with ultra-performance liquid chromatography-tandem mass spectrometry) were unaltered in preeclamptic versus healthy placentas. Most likely, this is due to enhanced l-tryptophan uptake, evidenced by increased l-tryptophan levels in preeclamptic placentas. Ex vivo perfused cotyledons from healthy and preeclamptic placentas released similar amounts of l-tryptophan and kynurenine pathway metabolites into the circulations. This release was not altered by adding l-tryptophan in the maternal circulation, suggesting that l-tryptophan metabolites act intracellularly. Maternally applied l-tryptophan did appear in the fetal circulation, confirming placental passage of this essential amino acid. After in vitro incubation of placental arteries with IDO1-upregulating cytokines interferon-γ and tumor necrosis factor-α, l-tryptophan induced vasodilation. This vasodilation was attenuated by both IDO1 and nitric oxide (NO) synthase inhibitors. Despite IDO1 downregulation, l-tryptophan-induced relaxation was enhanced in preeclamptic versus healthy placental arteries. However, cytokine stimulation additionally upregulated the LAT (l-type amino acid transporter) 1 in preeclamptic placental arteries only. Vasodilation to the lipophilic, transporter independent ethyl ester of l-tryptophan was reduced in preeclamptic versus healthy placental arteries, in agreement with reduced IDO1 expression. In conclusion, l-tryptophan induces IDO1- and NO-dependent relaxation in placental arteries, which is determined by l-tryptophan uptake rather than IDO1 expression. Increased l-tryptophan uptake might compensate for reduced IDO1 expression in preeclamptic placentas.


Assuntos
Indolamina-Pirrol 2,3,-Dioxigenase/efeitos dos fármacos , Placenta/irrigação sanguínea , Pré-Eclâmpsia/fisiopatologia , Triptofano/farmacologia , Vasodilatação/efeitos dos fármacos , Ácido 15-Hidroxi-11 alfa,9 alfa-(epoximetano)prosta-5,13-dienoico/farmacologia , Adulto , Artérias/metabolismo , Proteínas de Transporte/biossíntese , Proteínas de Transporte/genética , Citocinas/farmacologia , Indução Enzimática/efeitos dos fármacos , Feminino , Humanos , Indolamina-Pirrol 2,3,-Dioxigenase/genética , Indolamina-Pirrol 2,3,-Dioxigenase/metabolismo , Cinurenina/metabolismo , Troca Materno-Fetal , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase/antagonistas & inibidores , Placenta/efeitos dos fármacos , Placenta/metabolismo , Pré-Eclâmpsia/enzimologia , Gravidez , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Triptofano/análogos & derivados
12.
Cancers (Basel) ; 11(7)2019 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-31277254

RESUMO

High-risk non-metastatic prostate cancer (PCa) has the potential to progress into lethal disease. Treatment options are manifold but, given a lack of surrogate biomarkers, it remains unclear which treatment offers the best results. Several studies have reported circulating tumor cells (CTCs) to be a prognostic biomarker in metastatic PCa. However, few reports on CTCs in high-risk non-metastatic PCa are available. Herein, we evaluated CTC detection in high-risk non-metastatic PCa patients using the in vivo CellCollector CANCER01 (DC01) and CellSearch system. CTC counts were analyzed and compared before and after radiotherapy (two sampling time points) in 51 high-risk non-metastatic PCa patients and were further compared according to isolation technique; further, CTC counts were correlated to clinical features. Use of DC01 resulted in a significantly higher percentage of CTC-positive samples compared to CellSearch (33.7% vs. 18.6%; p = 0.024) and yielded significantly higher CTC numbers (range: 0-15 vs. 0-5; p = 0.006). Matched pair analysis of samples between two sampling time points showed no difference in CTC counts determined by both techniques. CTC counts were not correlated with clinicopathological features. In vivo enrichment using DC01 has the potential to detect CTC at a higher efficiency compared to CellSearch, suggesting that CTC is a suitable biomarker in high-risk non-metastatic PCa.

13.
Brief Funct Genomics ; 17(4): 255-264, 2018 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-29028900

RESUMO

The presence of microchimeric cells is known for >100 years and well documented since decades. Earlier, microchimeric cells were mainly used for cell-based non-invasive prenatal diagnostics during early pregnancy. Microchimeric cells are also present beyond delivery and are associated to various autoimmune diseases, tissue repair, cancer and immune tolerance. All these findings were based on low complexity studies and occasionally accompanied by artefacts not allowing the biological functions of microchimerism to be determined. However, with the recent developments in single-cell analysis, new means to identify and characterize microchimeric cells are available. Cell labelling techniques in combination with single-cell analysis provide a new toolbox to decipher the biology of microchimeric cells at molecular and cellular level. In this review, we discuss how recent developments in single-cell analysis can be applied to determine the role and function of microchimeric cells.


Assuntos
Quimerismo , Análise de Célula Única/métodos , Feminino , Perfilação da Expressão Gênica , Humanos , Gravidez , Diagnóstico Pré-Natal , Análise de Sequência de RNA
14.
J Vis Exp ; (135)2018 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-29863657

RESUMO

Rare target cells can be isolated from a high background of non-target cells using antibodies specific for surface proteins of target cells. A recently developed method uses a medical wire functionalized with anti-epithelial cell adhesion molecule (EpCAM) antibodies for in vivo isolation of circulating tumor cells (CTCs)1. A patient-matched cohort in non-metastatic prostate cancer showed that the in vivo isolation technique resulted in a higher percentage of patients positive for CTCs as well as higher CTC counts as compared to the current gold standard in CTC enumeration. As cells cannot be recovered from current medical devices, a new functionalized wire (referred to as Device) was manufactured allowing capture and subsequent detachment of cells by enzymatic treatment. Cells are allowed to attach to the Device, visualized on a microscope and detached using enzymatic treatment. Recovered cells are cytocentrifuged onto membrane-coated slides and harvested individually by means of laser microdissection or micromanipulation. Single-cell samples are then subjected to single-cell whole genome amplification allowing multiple downstream analysis including screening and target-specific approaches. The procedure of isolation and recovery yields high quality DNA from single cells and does not impair subsequent whole genome amplification (WGA). A single cell's amplified DNA can be forwarded to screening and/or targeted analysis such as array comparative genome hybridization (array-CGH) or sequencing. The device allows ex vivo isolation from artificial rare cell samples (i.e. 500 target cells spiked into 5 mL of peripheral blood). Whereas detachment rates of cells are acceptable (50 - 90%), the recovery rate of detached cells onto slides spans a wide range dependent on the cell line used (<10 - >50%) and needs some further attention. This device is not cleared for the use in patients.


Assuntos
Genoma/genética , Técnicas de Amplificação de Ácido Nucleico/métodos , Análise de Célula Única/métodos , Humanos
15.
Sci Rep ; 8(1): 5488, 2018 04 03.
Artigo em Inglês | MEDLINE | ID: mdl-29615752

RESUMO

Indoleamine 2,3-dioxygenase-1 (IDO1) mediates the degradation of L-tryptophan (L-Trp) and is constitutively expressed in the chorionic vascular endothelium of the human placenta with highest levels in the microvasculature. Given that endothelial expression of IDO1 has been shown to regulate vascular tone and blood pressure in mice under the condition of systemic inflammation, we asked whether IDO1 is also involved in the regulation of placental blood flow and if yes, whether this function is potentially impaired in intrauterine growth restriction (IUGR) and pre-eclampsia (PE). In the large arteries of the chorionic plate L-Trp induced relaxation only after upregulation of IDO1 using interferon gamma and tumor necrosis factor alpha. However, ex vivo placental perfusion of pre-constricted cotyledonic vasculature with L-Trp decreases the vessel back pressure without prior IDO1 induction. Further to this finding, IDO1 protein expression and activity is reduced in IUGR and PE when compared to gestational age-matched control tissue. These data suggest that L-Trp catabolism plays a role in the regulation of placental vascular tone, a finding which is potentially linked to placental and fetal growth. In this context our data suggest that IDO1 deficiency is related to the pathogenesis of IUGR and PE.


Assuntos
Vasos Sanguíneos/fisiopatologia , Endotélio Vascular/enzimologia , Retardo do Crescimento Fetal/enzimologia , Placenta/irrigação sanguínea , Pré-Eclâmpsia/enzimologia , Adulto , Artérias/fisiopatologia , Endotélio Vascular/metabolismo , Feminino , Retardo do Crescimento Fetal/patologia , Retardo do Crescimento Fetal/fisiopatologia , Regulação Enzimológica da Expressão Gênica , Humanos , Pré-Eclâmpsia/patologia , Pré-Eclâmpsia/fisiopatologia , Gravidez , Vasodilatação
16.
Curr Drug Metab ; 8(3): 205-8, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17430108

RESUMO

The mechanism of maternal immunotolerance of the semiallogeneic fetus has been a matter of intense investigation. The tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) is reported to be critically implicated. This article discusses findings pertaining to the role of IDO in pregnancy, its location at the feto-maternal interface, systemic induction of IDO in pregnancy and the association of IDO to spontaneous abortion and preeclampsia. Whereas there is a large body of evidence supporting the relevance of IDO as a key immunoregulatory factor in feto-maternal tolerance, open questions remain concerning as to its role.


Assuntos
Indolamina-Pirrol 2,3,-Dioxigenase/metabolismo , Placenta/enzimologia , Gravidez/metabolismo , Animais , Feminino , Humanos , Tolerância Imunológica , Indolamina-Pirrol 2,3,-Dioxigenase/imunologia , Pré-Eclâmpsia/enzimologia
17.
Sci Rep ; 7: 43424, 2017 02 24.
Artigo em Inglês | MEDLINE | ID: mdl-28233867

RESUMO

Enumeration and especially molecular characterization of circulating tumour cells (CTCs) holds great promise for cancer management. We tested a modified type of an in vivo enrichment device (Catch&Release) for its ability to bind and detach cancer cells for the purpose of single-cell molecular downstream analysis in vitro. The evaluation showed that single-cell analysis using array comparative genome hybridization (array-CGH) and next generation sequencing (NGS) is feasible. We found array-CGH to be less noisy when whole genome amplification (WGA) was performed with Ampli1 as compared to GenomePlex (DLRS values 0.65 vs. 1.39). Moreover, Ampli1-processed cells allowed detection of smaller aberrations (median 14.0 vs. 49.9 Mb). Single-cell NGS data obtained from Ampli1-processed samples showed the expected non-synonymous mutations (deletion/SNP) according to bulk DNA. We conclude that clinical application of this refined in vivo enrichment device allows CTC enumeration and characterization, thus, representing a promising tool for personalized medicine.


Assuntos
Separação Celular/métodos , Desenho de Equipamento , Neoplasias/diagnóstico , Células Neoplásicas Circulantes/metabolismo , Análise de Célula Única/métodos , Anticorpos/química , Anticorpos/metabolismo , Adesão Celular , Contagem de Células , Separação Celular/instrumentação , Hibridização Genômica Comparativa , Molécula de Adesão da Célula Epitelial/genética , Molécula de Adesão da Célula Epitelial/metabolismo , Expressão Gênica , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/patologia , Células Neoplásicas Circulantes/patologia , Medicina de Precisão , Análise de Célula Única/instrumentação
18.
J Reprod Immunol ; 56(1-2): 3-17, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12106880

RESUMO

Several members of the immunoglobulin-like transcript (ILT), also called leukocyte immunoglobulin-like receptor (LIR), family of transmembrane proteins have been identified as receptors for class I HLA molecules and transduce inhibitory signals to leukocytes upon binding of these ligands. The ligands for ILT2 (LIR1/CD85j) and ILT4 (LIR2/CD85d) include HLA-A, -B, and -G, the last of which is highly expressed in fetal trophoblast cells in both membrane-bound and soluble isoforms. To investigate the potential of fetally-derived HLA class I molecules to interact with maternal macrophages through these receptors, we examined the expression patterns of ILT2 and ILT4 in decidual macrophages. Highly purified populations of decidual macrophages were obtained by fluorescence activated cell sorting and were examined by RT-PCR for these messages. Analysis of mRNA from first trimester and term macrophages, as well as the monocyte cell line U937, resulted in amplicons of similar size to those expected for ILT2 and ILT4. Sequence analysis of the amplicons revealed that the messages from decidual macrophages corresponded to ILT2 and ILT4 messages. The message amplified from the U937 cells using the ILT2 primers was also found to be identical to ILT2; however, sequence analysis revealed that the ILT4 message amplified from these cells is a truncated form of the message. Dual label flow cytometry confirmed the expression of ILT2 and ILT4 on CD14-positive first trimester decidual macrophages and U937 cells. These results reveal that inhibitory HLA receptors are expressed in decidual macrophages and suggest that HLA-G may deliver negative signals to maternal decidual macrophages through interaction with these receptors.


Assuntos
Antígenos CD/fisiologia , Decídua/imunologia , Macrófagos/fisiologia , Receptores Imunológicos/fisiologia , Antígenos CD/análise , Antígenos CD/genética , Linhagem Celular , Feminino , Citometria de Fluxo , Humanos , Receptor B1 de Leucócitos Semelhante a Imunoglobulina , Glicoproteínas de Membrana , Gravidez , RNA Mensageiro/análise , Receptores Imunológicos/análise , Receptores Imunológicos/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa
19.
Toxicology ; 188(1): 35-48, 2003 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-12748040

RESUMO

Exposure to cadmium (Cd) can cause a variety of biological effects including alterations of immune responses in animals and humans. Both immunosuppression and immunoenhancement have been reported. The present study was aimed at investigating the consequences of exposure to Cd on the human immunoglobulin (Ig) E synthesis, using purified peripheral blood B lymphocytes and IL-4 and anti-human CD40 monoclonal antibody (a-CD40 mAb) as stimuli. Low concentrations of Cd (0.1-10 microM) markedly inhibited production of IgE in a concentration-dependent manner. IgG production, in contrast to IgE, showed a tendency towards being enhanced by Cd, although with a certain individual variability; IgM production was not affected. Cd failed to alter immediate surface expression of the activation markers CD69 and CD23 indicating that early activation events were not impaired. However, the portion of activated B cells was diminished by Cd after stimulation for more than 24 h, paralleled by a concomitant decrease in viability and a subsequent reduction in proliferation. These data suggest that the mechanism of Cd action on activated B cells involved pathways that interrupted an effectively initiated cell activation and induced a cytotoxic signal. Results from this study thus provide further evidence for and new information on the immunotoxic and immunomodulatory effects of Cd on human immune responses.


Assuntos
Linfócitos B/efeitos dos fármacos , Linfócitos B/metabolismo , Cádmio/toxicidade , Imunoglobulina E/biossíntese , Adulto , Anticorpos Monoclonais/imunologia , Antígenos CD/biossíntese , Antígenos CD/imunologia , Antígenos de Diferenciação de Linfócitos T/biossíntese , Antígenos de Diferenciação de Linfócitos T/imunologia , Linfócitos B/citologia , Linfócitos B/imunologia , Antígenos CD40/imunologia , Sobrevivência Celular/imunologia , Relação Dose-Resposta Imunológica , Feminino , Citometria de Fluxo , Humanos , Imunoglobulina E/imunologia , Imunoglobulina E/metabolismo , Imunoglobulina G/biossíntese , Imunoglobulina G/imunologia , Imunoglobulina M/biossíntese , Imunoglobulina M/imunologia , Interleucina-4/imunologia , Lectinas Tipo C , Ativação Linfocitária/imunologia , Masculino , Pessoa de Meia-Idade , Receptores de IgE/biossíntese , Receptores de IgE/imunologia
20.
J Biochem Biophys Methods ; 53(1-3): 109-15, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12406592

RESUMO

We compared instrumental analysis of enriched cord blood nucleated red blood cells (CB-NRBC) out of in vitro contamination preparations of dilutions of minute volumes of male cord blood into peripheral blood from nonpregnant women. This was done using the laser scanning cytometer (LSC) and the Metafer/RCDetect microscope scanning system, both allowing for relocation of positive cells defined on the basis of fluorescence parameters. Both instruments were efficient in performing scanning and relocation; a difference in the recovery of CB-NRBC was not significant and can be explained by the method of preparation used.


Assuntos
Separação Celular/instrumentação , Eritroblastos/classificação , Eritroblastos/citologia , Sangue Fetal/citologia , Citometria de Fluxo/instrumentação , Microscopia de Fluorescência/instrumentação , Animais , Análise de Falha de Equipamento , Feminino , Humanos , Citometria por Imagem/instrumentação , Hibridização in Situ Fluorescente , Recém-Nascido , Lasers , Masculino , Troca Materno-Fetal , Microscopia Confocal/métodos , Gravidez , Cromossomo Y
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA